bioMérieux (France)

bioMérieux (France)

bioMérieux SA is a French multinational biotechnology company founded and headquartered in Marcy-l'Étoile, France, close to Lyon. bioMérieux is present in 44 countries and serves more than 160 countries through a large network of distributors. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for bioMérieux (France), France, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

59%


Total
Publications

1.5K


Total Open
Publications

877


Total
Citations

51K


Open Access
Percentage

59%


Total
Publications

1.5K


Total Open
Publications

877


Total
Citations

51K

Wikipedia

Website

download

Breakdown

14% 35% 8% 43%

Publisher Open

14%

Both

35%

Other Platform Open

8%

Closed

43%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090100110Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

59%OA Journal

OA Journal 59%

421

Hybrid 18%

129

No Guarantees 23%

168

Other Platform Open

Domain 78%

491

Institution 47%

295

Other Internet 17%

105

Public 4%

23

Preprint 1%

8

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
490
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
158
DOI
Other Internet
102
DANS - Data Archiving and Networked Services
Institution
85
Europe PMC
Domain
35
Erasmus University, Rotterdam - RePub
Institution
31
Figshare
Public
21
University of Groningen / Centre for Information Technology - University of Groningen research database
Institution
10
Imperial College London - Spiral
Institution
9
Washington University School of Medicine - Digital Commons@Becker
Institution
8
1 / 9

Data updated 18 August 2025

Share

Share

Share